{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:49:25Z","timestamp":1792316965817,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016350","name":"Sichuan Provincial Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2024MS149"],"award-info":[{"award-number":["2024MS149"]}],"id":[{"id":"10.13039\/501100016350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013091","name":"Science and Technology Major Project of Guangxi","doi-asserted-by":"publisher","award":["AA23073012"],"award-info":[{"award-number":["AA23073012"]}],"id":[{"id":"10.13039\/501100013091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693953"],"award-info":[{"award-number":["2021M693953"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32060018"],"award-info":[{"award-number":["32060018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360035"],"award-info":[{"award-number":["32360035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472328"],"award-info":[{"award-number":["82472328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025NSFSC2139"],"award-info":[{"award-number":["2025NSFSC2139"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jconrel.2025.114596","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:36:21Z","timestamp":1767339381000},"page":"114596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A biomimetic nanovesicle derived from BCG-primed macrophages with mannose modification for targeted immunotherapy against cryptococcal meningitis"],"prefix":"10.1016","volume":"391","author":[{"given":"Yanqiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biaoliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jconrel.2025.114596_bb0005","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","volume":"22","author":"Rajasingham","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114596_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114596_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02155-23","article-title":"Elements of dissemination in cryptococcosis","volume":"15","author":"Bednarek","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.jconrel.2025.114596_bb0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fmicb.2016.00105","article-title":"Cryptococcus and phagocytes: complex interactions that influence disease outcome","volume":"7","author":"Leopold Wager","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jof4010033","article-title":"Innate immunity against Cryptococcus, from recognition to elimination","volume":"4","author":"Campuzano","year":"2018","journal-title":"J. Fungi"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41572-023-00472-z","article-title":"Cryptococcal meningitis","volume":"9","author":"Tugume","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114596_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jof10040278","article-title":"Amphotericin B in the era of new antifungals: where will it stand?","volume":"10","author":"Akinosoglou","year":"2024","journal-title":"J. Fungi"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114596_bb0040","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1128\/AAC.02535-14","article-title":"In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier","volume":"58","author":"Wu","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114596_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13020128","article-title":"Antifungal resistance in cryptococcal infections","volume":"13","author":"Melhem","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00142-23","article-title":"Advancements and challenges in antifungal therapeutic development","volume":"37","author":"Puumala","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0060","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2288797","article-title":"Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective","volume":"30","author":"Li","year":"2023","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114596_bb0065","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ad4aaa","article-title":"Macrophage membrane-coated nanoparticles for the treatment of infectious diseases","volume":"19","author":"Wang","year":"2024","journal-title":"Biomed. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114596_bb0070","article-title":"Biomedical applications of cell membrane-based biomimetic Nano-delivery system","volume":"7","author":"Zhang","year":"2024","journal-title":"Adv. Ther."},{"issue":"50","key":"10.1016\/j.jconrel.2025.114596_bb0075","doi-asserted-by":"crossref","first-page":"34219","DOI":"10.1021\/acsnano.4c11658","article-title":"Targeted initiation of trained immunity in tumor-associated macrophages with membrane-camouflaged Bacillus Calmette-Guerin for lung carcinoma immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114596_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"issue":"10","key":"10.1016\/j.jconrel.2025.114596_bb0085","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.7150\/thno.81520","article-title":"Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0090","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114596_bb0095","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","article-title":"Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles","volume":"19","author":"Li","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","article-title":"Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies","volume":"23","author":"Mehdizadeh","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114596_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108387","article-title":"BCG vaccination induces long-term functional reprogramming of human neutrophils","volume":"33","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114596_bb0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"43","key":"10.1016\/j.jconrel.2025.114596_bb0125","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114596_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14020196","article-title":"Beyond tuberculosis: the surprising immunological benefits of the Bacillus Calmette-Guerin (BCG) vaccine in infectious, auto-immune, and inflammatory diseases","volume":"14","author":"Jurczak","year":"2025","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114596_bb0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4049\/jimmunol.2200642","article-title":"Bacillus Calmette-Guerin-trained macrophages elicit a protective inflammatory response against the pathogenic bacteria Brucella abortus","volume":"211","author":"de Araujo","year":"2023","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114596_bb0140","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s44211-024-00649-w","article-title":"Development of molecular sensors based on fluorescent proteins for polarized macrophages identification","volume":"40","author":"Bandaranayake","year":"2024","journal-title":"Anal. Sci."},{"issue":"530","key":"10.1016\/j.jconrel.2025.114596_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114596_bb0150","first-page":"197","article-title":"Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting","volume":"17","author":"Hatami","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114596_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061685","article-title":"Mannose-coated reconstituted lipoprotein nanoparticles for the targeting of tumor-associated macrophages: optimization, characterization, and in vitro evaluation of effectiveness","volume":"15","author":"Dossou","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114596_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107253","article-title":"Isobavachalcone: a redox antifungal agent impairs the mitochondria protein of Cryptococcus neoformans","volume":"64","author":"Wang","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7927","key":"10.1016\/j.jconrel.2025.114596_bb0165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-022-05125-x","article-title":"Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation","volume":"609","author":"Stafford","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114596_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114596_bb0175","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40364-025-00750-w","article-title":"Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114596_bb0185","article-title":"Cryptococcosis and cryptococcal meningitis: a narrative review and the up-to-date management approach","volume":"16","author":"Qureshi","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114596_bb0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2025.114596_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00264-13","article-title":"Macrophage M1\/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection","volume":"4","author":"Davis","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.jconrel.2025.114596_bb0200","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fphar.2019.00751","article-title":"Bioinspired and biomimetic nanotherapies for the treatment of infectious diseases","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114596_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103991","article-title":"Multifaceted therapeutic applications of biomimetic nanovaccines","volume":"29","author":"Chheda","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.jconrel.2025.114596_bb0210","first-page":"69","article-title":"Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization","volume":"23","author":"Huang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.114596_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102241","article-title":"Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis","volume":"95","author":"Huang","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"18","key":"10.1016\/j.jconrel.2025.114596_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300404","article-title":"Cell-based biomaterials for coronavirus disease 2019 prevention and therapy","volume":"12","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114596_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105483","article-title":"Pharmacological review of isobavachalcone, a naturally occurring chalcone","volume":"165","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925012106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925012106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:40:24Z","timestamp":1781772024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925012106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S0168365925012106"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114596","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A biomimetic nanovesicle derived from BCG-primed macrophages with mannose modification for targeted immunotherapy against cryptococcal meningitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114596"}}